68 related articles for article (PubMed ID: 17037023)
1. [Chemotherapy guidance of the drug sensitivity test in vitro in human laryngeal squamous cell carcinoma].
Zhang S; Kong W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Aug; 20(15):711-3. PubMed ID: 17037023
[TBL] [Abstract][Full Text] [Related]
2. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
4. Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatin.
Jaglowski JR; Stack BC
Cancer Lett; 2006 Nov; 243(1):58-63. PubMed ID: 16412572
[TBL] [Abstract][Full Text] [Related]
5. [Study on the effects of taxol on Hep-2 cell lines in larynx carcinoma].
Ni G; Dong Y; Wang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):265-7. PubMed ID: 12563982
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.
Xie M; Zhou L; Hu T; Yao M
Anticancer Drugs; 2007 Apr; 18(4):459-66. PubMed ID: 17351398
[TBL] [Abstract][Full Text] [Related]
7. [The expression of c-myc in the tissues of human laryngeal squamous cell carcinoma and the effect of siRNA-mediated inhibition of c-myc on proliferation in laryngeal carcinoma Hep-2 cells].
Sang J; Liu L; Tian F; Jin H; Yuan L; Lou W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 25(15):695-700. PubMed ID: 22010341
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
[TBL] [Abstract][Full Text] [Related]
9. An in vitro study of cytotoxic effects of gossypol on human epidermoid larynx carcinoma cell line (HEp-2).
Konac E; Ekmekci A; Yurtcu E; Ergun MA
Exp Oncol; 2005 Mar; 27(1):81-3. PubMed ID: 15812364
[TBL] [Abstract][Full Text] [Related]
10. [The effect of sodium phenylbutyrate to agents used in induction chemotherapy on laryngeal carcinoma cells Hep-2 in vitro].
Gao J; Ruan X; Pan X; Xu F; Lei D; Liu D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Aug; 19(15):680-2. PubMed ID: 16248503
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of human laryngeal cancer Hep-2 cells by taxol].
Jiang X; Chen W; Cui P; Zhang D; Zhang Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jun; 17(6):342-5. PubMed ID: 14503369
[TBL] [Abstract][Full Text] [Related]
12. Methyl-beta-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: involvement of Akt, NF-kappaB and Bcl-2.
Upadhyay AK; Singh S; Chhipa RR; Vijayakumar MV; Ajay AK; Bhat MK
Toxicol Appl Pharmacol; 2006 Oct; 216(2):177-85. PubMed ID: 16806341
[TBL] [Abstract][Full Text] [Related]
13. Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor.
McLaughlin PJ; Jaglowski JR; Verderame MF; Stack BC; Leure-Dupree AE; Zagon IS
Int J Oncol; 2005 Mar; 26(3):809-16. PubMed ID: 15703840
[TBL] [Abstract][Full Text] [Related]
14. Endometrial cancer cell lines are sensitive to paclitaxel.
Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of human laryngeal squamous cell carcinoma Hep-2 to metrotexate chemoterapy.
Galbiatti AL; Caldas HC; Padovani JA; Pavarino EC; Goloni-Bertollo EM
Exp Oncol; 2012 Dec; 34(4):367-9. PubMed ID: 23302998
[TBL] [Abstract][Full Text] [Related]
16. [Synergistic interactions of TRAIL and paclitaxel on the laryngeal squamous carcinoma cell line in vitro].
Zhang M; Zhou L; Xie M; Tian J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1105-8. PubMed ID: 18330255
[TBL] [Abstract][Full Text] [Related]
17. [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Chen W; Zhou X; Xu Q; Guo W; Lin L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):404-7. PubMed ID: 12641948
[TBL] [Abstract][Full Text] [Related]
18. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
Rigalli JP; Reuter T; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Theile D
Cancer Chemother Pharmacol; 2013 May; 71(5):1335-43. PubMed ID: 23479137
[TBL] [Abstract][Full Text] [Related]
19. [Apoptosis inducing effect by TRAIL on human laryngeal squamous carcinoma Hep-2 cells].
Yao H; Xiao H; Wang C; Liu M; Jin D
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Feb; 25(3):127-9. PubMed ID: 21553526
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial effects of geopropolis produced by Melipona fasciculata Smith with anticancer drugs against human laryngeal epidermoid carcinoma (HEp-2) cells.
Bartolomeu AR; Frión-Herrera Y; da Silva LM; Romagnoli GG; de Oliveira DE; Sforcin JM
Biomed Pharmacother; 2016 Jul; 81():48-55. PubMed ID: 27261576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
